Lisa Villabona

Publications
CV
Public outreach and news

Articles

Article: JID INNOVATIONS. 2025;5(3):100355
IGF2BP3 As a Prognostic Biomarker and Regulator of Metastasis in Merkel Cell Carcinoma
Yang Y; Gao J; Shi H; Sihto H; Kilpinen S; Vilcot F; Janska L; Jeschonneck J; Cvetanovic T; Hoog A; Siarov J; Paoli J; Juhlin CC; Villabona L; Larsson C; Lui W-O
Article: AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. 2024;25(6):987-996
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study
Mortier L; Villabona L; Lawrence B; Arance A; Butler MO; Beylot-Barry M; Saiag P; Samimi M; Ascierto PA; Spada F; De Pontville M; Maio M; Berrocal A; Espinosa E; Capdevila J; Levin M; Das D; Krepler C; Grebennik D; Chiarion-Sileni V
Article: CANCERS. 2020;12(11):E3238-3238
Prognostic Interactions between FAP plus Fibroblasts and CD8a+T Cells in Colon Cancer
Herrera M; Mezheyeuski A; Villabona L; Corvigno S; Strell C; Klein C; Holzlwimmer G; Glimelius B; Masucci G; Sjoblom T; Ostman A
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(15_suppl):e15069
Analysis of the management of immunotherapy-derived toxicity in the Stockholm region.
Villabona LEE; Huopaniemi O
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(15_suppl):e22063
Effectiveness of PD1-inhibitors in advanced Merkel cell carcinoma: Real life data in a Swedish cohort.
Bjorn-Andtback H; Masucci GV; Villabona LEE
Article: ONCOIMMUNOLOGY. 2016;5(1):e1052213
Non-classical HLA-class I expression in serous ovarian carcinoma: Correlation with the HLA-genotype, tumor infiltrating immune cells and prognosis
Andersson E; Poschke I; Villabona L; Carlson JW; Lundqvist A; Kiessling R; Seliger B; Masucci GV
Article: MODERN PATHOLOGY. 2014;27(9):1296-1305
A novel approach for HLA-A typing in formalin-fixed paraffin-embedded-derived DNA
Villabona L; Leon Rodriguez DA; Andersson EK; Seliger B; Dalianis T; Masucci GV
Article: ANTICANCER RESEARCH. 2014;34(5):2369-2375
HLA-A*02 in Relation to Outcome in Human Papillomavirus Positive Tonsillar and Base of Tongue Cancer
Tertipis N; Villabona L; Nordfors C; Nasman A; Ramqvist T; Vlastos A; Masucci G; Dalianis T
Article: METHODS IN MOLECULAR BIOLOGY. 2014;1102:353-366
Genotyping of human leukocyte antigen (HLA) ancestral haplotypes as prognostic marker in cancer using PCR analysis.
Villabona L; Andersson E; Marchesi M; Masucci GV
Article: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2012;61(8):1243-1253
Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancer
Andersson E; Villabona L; Bergfeldt K; Carlson JW; Ferrone S; Kiessling R; Seliger B; Masucci GV
Journal article: JOURNAL OF NUCLEIC ACIDS INVESTIGATION. 2010;1(1):9
Survival of the fittest or best adapted: HLA-dependent tumor development
Masucci GV; Andersson E; Villabona L; Helgadottir H; Bergfeldt K; Cavallo F; Forni G; Ferrone S; Choudhury A; Seliger B; Kiessling R
Journal article: JOURNAL OF NUCLEIC ACIDS INVESTIGATION. 2010;1(1):9
Survival of the fittest or best adapted: HLA-dependent tumor development
Masucci GV; Andersson E; Villabona L; Helgadottir H; Bergfeldt K; Cavallo F; Forni G; Ferrone S; Choudhury A; Seliger B; Kiessling R
Article: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2009;58(10):1599-1608
The common Scandinavian human leucocyte antigen ancestral haplotype 62.1 as prognostic factor in patients with advanced malignant melanoma
Helgadottir H; Andersson E; Villabona L; Kanter L; van der Zanden H; Haasnoot GW; Seliger B; Bergfeldt K; Hansson J; Ragnarsson-Olding B; Kiessling R; Masucci GV
Article: HLA. 2007;70(3):205-213
Analysis of HLA class I-II haplotype frequency and segregation in a cohort of patients with advanced stage ovarian cancer
Gamzatova Z; Villabona L; van der Zanden H; Haasnoot GW; Andersson E; Kiessling R; Seliger B; Kanter L; Dalianis T; Bergfeldt K; Masucci GV
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2007;25(18_suppl):21059
Lack of p21/Waf-1 expression and lymphocyte infiltration in primary ovarian cancer correlate with the somatic HLA-A2 expression
Andersson E; Villabona L; Kanter L; Gamzatova Z; Kiessling R; Dalianis T; Bergfeldt K; Masucci GV
Article: ARKHIV PATOLOGII. 2006;68(6):3-6
[Expression of the major histocompability complex HLA-A2 gene in ovarian cancer].
Kostiuchek DF; Anichkov NM; Gamzatova ZK; Masucchi GV; Bergfedt K; Villabona L
Article: GYNECOLOGIC ONCOLOGY. 2006;103(1):145-150
Human leucocyte antigen (HLA) A2 as a negative clinical prognostic factor in patients with advanced ovarian cancer
Gamzatova Z; Villabona L; Dahlgren L; Dalianis T; Nillson B; Bergfeldt K; Masucci GV
Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2005;23(16_suppl):5096
Human leucocyte antigen (HLA) A2 phenotype incidence in patients with advanced ovarian cancer as negative clinical prognostic factor
Masucci GV; Gamzatova Z; Villabona L; Dahlgren L; Dalianis T; Åvall-Lundqvist E; Bergfeldt K

Employments

Adjunct Lecturer, Department of Oncology-Pathology, Karolinska Institutet, 2026-2027
Affiliated to Research, Department of Oncology-Pathology, Karolinska Institutet, 2023-2026

Degrees and Education

Degree Of Doctor Of Philosophy, Department of Oncology-Pathology, Karolinska Institutet, 2016
University Medical Degree, Karolinska Institutet, 2011

Articles

Employments

Degrees and Education

Distinction and awards

Supervision

Conference/event participation

News from KI

Events from KI